Parallax Volatility Advisers, L.P. Surface Oncology, Inc. Call Options Transaction History

Parallax Volatility Advisers, L.P.

2 transactions

Quarter	Operation	Price Per call	calls change	calls Held	SEC Form
Q3 2021 Nov 15, 2021	SELL	$5.16 - $7.98 $397,320 - $614,460	-77,000 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$6.45 - $9.09 $496,650 - $699,930	77,000 New	77,000 $575,000

315K

Ticker SURF
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 58,034,000
Description
Surface Oncology, Inc., a clinical-stage immuno-oncology company, engages in the development of cancer therapies in the United States. The company develops various antibodies that include NZV930, a fully human immunoglobulin isotype G4 monoclonal antibody for the production of extracellular adenosine; SRF617, a fully human IgG4 monoclonal antibo...

Get notified when there are updates to the investment portfolio of Parallax Volatility Advisers, L.P., based on Form 13F filings with the SEC.

Stay updated on Parallax Volatility Advisers, L.P. with notifications on news.